ASH 2016: Dr. Wiestner on Predicting Ibrutinib resistance

[bkoffman]

This week I'm posting the final installment of my 3-part interview with Dr. Adrian Wiestner from the NIH where we discussed which CLL patients are more likely to relapse when being treated with ibrutinib and the options that are available if that happens. You can read my summary, and watch the interview here: cllsociety.org/2017/06/cll-...

TOMORROW, the 2nd 2017 issue of The CLL Tribune will be published. Watch your email and set aside some time to read the fantastic articles in this issue, written by both patients and CLL experts. Very cool

Stay strong.

We are all in this together.

Brian

cllsociety.org

bkoffman.blogspot.com

[LoganS]

Thank Dr koffman for bringing much knowledge and positivity to us CLL patients!

[maggiesgrandmom]

The new newsletter was helpful and well designed. Thank you.